Back to the main directory
Company Analysis / Equity
- MPLX Reports Good 2Q Results; Expands in Permian by Morningstar
- Morningstar | Deutsche Boerse's renewed commitment to growth and cost discipline focus should drive profitability. by Morningstar
- Valero Energy Partners Reports Solid 2Q; Waiting for 2018 Drop-Down by Morningstar
- Morningstar | Valero Energy Partners Reports Solid 2Q; Waiting for 2018 Drop-Down by Morningstar
- Morningstar | Reliance Steel & Aluminum Posts Record Profits Thanks to 21% Sales Growth and Gross Margins Over 30% by Morningstar
- Morningstar | Allergan's Top-Line Phase 3 Results for Abicipar Don't Shift Our View for Now by Morningstar
- Morningstar | Roche's 2Q Reflects Ocrevus Strength as Biosimilar Competition Intensifies; Shares Undervalued by Morningstar
- Xerox Struggles With Profitability in Strategic Transformation; Maintaining Our $32 FVE by Morningstar
- While Accelerating Sales and Profits Have Proved Elusive, Hershey Is Showing It's on Right Course by Morningstar
- Morningstar | Allergan Posts Impressive 2Q While Awaiting Generic Restasis; Shares Still Look Undervalued by Morningstar
- Morningstar | Xerox Struggles With Profitability in Strategic Transformation; Maintaining Our $32 FVE by Morningstar
- Morningstar | McKesson Reports a Solid Quarter as Potential Shifts in Market Dynamics Take Center Stage by Morningstar
- Morningstar | ONETractor Efforts Continues to Drive Traffic to Tractor Supply, Leading to Improved Profitability by Morningstar
- Morningstar | ConocoPhillips Increases Share Repurchase Plans and Hits Debt Targets Early by Morningstar
- Morningstar | Production discipline by Cameco and NAC KazAtomProm help set the stage for price recovery. by Morningstar
- Martin Marietta Shares Trade Lower After 2Q Earnings, but Free Cash Flow Growth Outlook Still Strong by Morningstar
- Morningstar | Martin Marietta Shares Trade Lower After 2Q Earnings, but Free Cash Flow Growth Outlook Still Strong by Morningstar
- Accor's Brand Advantage Intact, Despite Ongoing Challenges in New Businesses; Shares Fairly Valued by Morningstar
- More Buybacks for Suncor, but Stock Remains in 3-Star Territory by Morningstar
- Morningstar | Cameco Extends Shutdown of McArthur River and Key Lake Indefinitely as Uranium Price Slow to Recover by Morningstar
- More Buybacks for Suncor, but Stock Remains in 3-Star Territory by Morningstar
- Morningstar | More Buybacks for Suncor, but Stock Remains in 3-Star Territory. See Updated Analyst Note from 26 Jul 2018 by Morningstar
- Morningstar | More Buybacks for Suncor, but Stock Remains in 3-Star Territory by Morningstar
- Buoyed by Recently Launched Branded Drugs, Novartis Posts Steady 2Q by Morningstar
- We anticipate increasing supply will weigh on product pricing and PCA's returns in the coming years. by Morningstar
- Morningstar | Canfor adjusted EBITDA Nearly Doubles on Strong Lumber, Pulp Pricing in 2Q by Morningstar
- More Steady Growth for Deutsche Boerse; Slightly Higher One-Time Charges Than Normal by Morningstar
- Morningstar | More Steady Growth for Deutsche Boerse; Slightly Higher One-Time Charges Than Normal by Morningstar
- Morningstar | We forecast lower profits ahead for Reliance as prices soften and market conditions normalize. by Morningstar
- Roche's 2Q Reflects Ocrevus Strength as Biosimilar Competition Intensifies; Shares Undervalued by Morningstar
- Roche's 2Q Reflects Ocrevus Strength as Biosimilar Competition Intensifies; Shares Undervalued by Morningstar
- West Reports Better-Than-Expected 2Q Results; Raising FVE by Morningstar
- Morningstar | Roche's 2Q Reflects Ocrevus Strength as Biosimilar Competition Intensifies; Shares Undervalued by Morningstar
- McKesson Reports a Solid Quarter as Potential Shifts in Market Dynamics Take Center Stage by Morningstar
- Morningstar | West Reports Better-Than-Expected 2Q Results; Raising FVE by Morningstar
- Morningstar | While Accelerating Sales and Profits Have Proved Elusive, Hershey Is Showing It's on Right Course by Morningstar
- ONETractor Efforts Continues to Drive Traffic to Tractor Supply, Leading to Improved Profitability by Morningstar
- Production discipline by Cameco and NAC KazAtomProm help set the stage for price recovery. by Morningstar
- Production discipline by Cameco and NAC KazAtomProm help set the stage for price recovery. by Morningstar
- Morningstar | Martin Marietta Shares Trade Lower After 2Q Earnings, but Free Cash Flow Growth Outlook Still Strong. See Updated Analyst Note from 26 Jul 2018 by Morningstar
- Morningstar | Production discipline by Cameco and NAC KazAtomProm help set the stage for price recovery. by Morningstar
- Celgene's Strong 2Q Largely Reflected in Our FVE; Cell Therapy Remains Key Catalyst by Morningstar
- Morningstar | Celgene's Strong 2Q Largely Reflected in Our FVE; Cell Therapy Remains Key Catalyst by Morningstar
- Morningstar | Accor's Brand Advantage Intact, Despite Ongoing Challenges in New Businesses; Shares Fairly Valued by Morningstar
- Morningstar | Cameco Extends Shutdown of McArthur River and Key Lake Indefinitely as Uranium Price Slow to Recover by Morningstar
- EOTF Positions McDonald's for Long-Term U.S. Comp Growth, Despite Near-Term Promotional Tweaks by Morningstar
- Morningstar | More Buybacks for Suncor, but Stock Remains in 3-Star Territory. See Updated Analyst Note from 26 Jul 2018 by Morningstar
- Morningstar | More Buybacks for Suncor, but Stock Remains in 3-Star Territory by Morningstar
- Morningstar | EOTF Positions McDonald's for Long-Term U.S. Comp Growth, Despite Near-Term Promotional Tweaks by Morningstar
- Telefonica Reported Mixed 2Q Results With Weak Revenue, but Improved Margins; Shares Undervalued by Morningstar